National Health Investors (NHI) Reports Q4 Normalized FFO of $1.27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Cantor Fitzgerald Remains Sidelined on National Health Investors (NHI) After Adjusting Estimates
February 21, 2017 6:55 AM ESTCantor Fitzgerald reiterated a Neutral rating and $75.00 price target on National Health Investors (NYSE: NHI) after adjusting estimates. Cantor lowered 2017 normalized FFO estimates to $5.10 (from $5.17) compared with the $5.16 consensus and the $5.06-5.12 guidance. Cantor also initiated a 2018 normalized FFO estimate of $5.30 compared to consensus of... More
National Health Investors (NHI) Raises Quarterly Dividend 5.6% to $0.95; 5.1% Yield
February 17, 2017 5:47 AM ESTNational Health Investors (NYSE: NHI) declared a quarterly dividend of $0.95 per share, or $3.8 annualized. This is a 5.6% increase from the prior dividend of $0.90.
The dividend will be payable on May 10, 2017, to stockholders of record on March 31, 2017, with an ex-dividend date of March 29,... More
